Title : Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.

Pub. Date : 2010

PMID : 23074402






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The INTEREST trial further indicated that patients with EGFR mutations had prolonged PFS and higher ORR when treated with gefitinib compared with docetaxel. Docetaxel epidermal growth factor receptor Homo sapiens